GlassScriptPhysician profile
Mark B Swierczek
NPI 1710577259
$2,633.83
in general payments reported to CMS, 2019-2025
15 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $594 · 2023: $1,092 · 2024: $472 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,039.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,039.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $844.37 | 2022-2025 | Collagenase Santyl, Allevyn Life L 15.4x15.4 Ctn10, Renasys Go V2 Home |
| Bioventus LLC | $744.30 | 2022-2023 | Theragenesis Bilayer Wound Matrix, Sonicone Clinic |
| Lifenet Health | $226.73 | 2023-2025 | Theragenesis Wound Matrix |
| Hydrofera LLC | $155.91 | 2023-2025 | Hydrofera Blue |
| Nevro Corp. | $131.86 | 2023 | Senza |
| Medtronic, INC. | $113.99 | 2022 | |
| Next Science LLC | $76.72 | 2023-2024 | Xperience, Blastx, Surgx |
| Paratek Pharmaceuticals, INC. | $70.43 | 2023-2025 | Nuzyra |
| Boston Scientific Corporation | $63.39 | 2023-2025 | Watchman Flx |
| Melinta Therapeutics, LLC | $59.89 | 2023-2024 | Kimyrsa, Orbactiv |
| Coloplast Corp | $40.64 | 2024-2025 | |
| Bsn Medical INC | $32.99 | 2025 | |
| Convatec INC. | $32.40 | 2023-2025 | |
| Globus Medical, INC. | $26.53 | 2025 | Senza |
| Kestra Medical Technology Services, INC. | $13.68 | 2023 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Swierczek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.